[1]胡学俊,马小林,刘 冰,等.药物涂层球囊治疗新生冠状动脉病变45例临床分析 [J].介入放射学杂志,2020,29(12):1258-1261.
 HU Xuejun,MA Xiaoling,LIU Bing,et al.Drug-coated balloon for the treatment of de novo coronary lesions: clinical analysis of 45 patients[J].journal interventional radiology,2020,29(12):1258-1261.
点击复制

药物涂层球囊治疗新生冠状动脉病变45例临床分析 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
29
期数:
2020年12
页码:
1258-1261
栏目:
临床研究
出版日期:
2020-12-25

文章信息/Info

Title:
Drug-coated balloon for the treatment of de novo coronary lesions: clinical analysis of 45 patients
作者:
胡学俊 马小林 刘 冰 黄 政 方存明
Author(s):
HU Xuejun MA Xiaoling LIU Bing HUANG Zheng FANG Cunming.
Department of Cardiology, Xuancheng Municipal People’s Hospital, Xuancheng, Anhui Province 242000, China
关键词:
【关键词】 药物涂层球囊 新生病变 冠状动脉病变
文献标志码:
A
摘要:
【摘要】 目的 探讨药物涂层球囊(DCB)治疗新生冠状动脉病变的可行性、有效性和安全性。方法 回顾性分析2017年4月至2018年8月宣城市人民医院45例新生冠状动脉病变患者DCB介入治疗过程及其临床和影像学随访结果。结果 手术成功率为100%。术后定量冠状动脉造影(QCA)分析显示急性管腔内径增加(1.67±0.29) mm,即刻残余狭窄为(17.78±7.94)%。术后9~12个月复查冠状动脉造影显示远期管腔丢失(0.12±0.21) mm。术后12~30个月临床随访显示,4例(8.9%)发生靶血管血运重建(TVR),其中2例在靶病变。未发生心源性死亡、非致死性目标血管心肌梗死或靶血管血栓形成。结论 DCB治疗新生冠状动脉病变可行且安全有效,随访期主要不良心脏事件发生率低,提示DCB可作为新生冠状动脉病变介入治疗的良好选择。

参考文献/References:

[1] Kalra A, Rehman H, Khera S, et al. New- generation coronary stents: current data and future directions[J]. Curr Atheroscler Rep, 2017, 19: 14.
[2] Benjamin EJ,Blaha MJ,Chiuve SE,et al. Heart disease and stroke statistics- 2017 update[J]. Circulation, 2017, 135:e146- e603.
[3] Ismail MD, wan Ahmad WA, Leschke M, et al. The outcomes of patients with very small coronary artery disease treated with thin strut cobalt chromium bare metal stents: an observational study[J]. Springerplus, 2016, 5: 1668.
[4] Megaly M, Rofael M, Saad M, et al. Outcomes with drug- coated balloons in small- vessel coronary artery disease[J]. Catheter Cardiovasc Interv, 2019, 93:E277- E286.
[5] Jackson D, Tong D, Layland J. A review of the coronary applications of the drug coated balloon[J]. Int J Cardiol, 2017, 226: 77- 86.
[6] Harada Y, Colleran R, Pinieck S, et al. Angiographic and clinical outcomes of patients treated with drug- coated balloon angioplasty for in- stent restenosis after coronary bifurcation stenting with a two- stent technique[J]. EuroIntervention, 2017, 12: 2132- 2139.
[7] Sim HW, Ananthakrishna R, Chan SP, et al. Treatment of very small de novo coronary artery disease with 2.0 mm drugcoated balloons showed 1- year clinical outcome comparable with 2.0 mm drug- eluting stents[J]. J Invasive Cardiol, 2018, 30: 256- 261.
[8] Sinaga DA, Ho HH, Watson TJ, et al. Drug- coated balloons: a safe and effective alternative to drug- eluting stents in small vessel coronary artery disease[J]. J Interv Cardiol, 2016, 29: 454- 460.
[9] 《药物涂层球囊临床应用中国专家共识》专家组. 药物涂层球囊临床应用中国专家共识[J]. 中国介入心脏病学杂志, 2016,24:61- 67.
[10] 刘 成,黄 定,陈 伟,等. 药物涂层球囊与药物涂层支架治疗老年支架内再狭窄的有效性和安全性[J]. 实用老年医学, 2018, 32:626- 629.
[11] 曾书燚,王正东,陈 坚,等. 药物洗脱球囊与药物洗脱支架治疗支架内再狭窄疗效比较[J]. 介入放射学杂志, 2017, 26:839- 842.
[12] 谢江波,陈 晖,温燕华,等. 药物涂层球囊在冠状动脉小血管病变中的疗效[J]. 实用医学杂志, 2019, 35:1092- 1095.
[13] Jeger RV, Farah A, Ohlow MA, et al. Drug- coated balloons for small coronary artery disease(BASKET- SMALL 2): an open- label randomised non- inferiority trial[J]. Lancet, 2018, 392: 849- 856.
[14] Rosenberg M, Waliszewski MP. Large- scale multicenter trial for the use of drug- coated balloons in coronary lesions: the DCB- only All- Comers Registry[J]. Catheter Cardiovasc Interv, 2019, 93: 181- 188.
[15] Liu Y, Zhang YJ, Deng LX, et al. 12- month clinical results of drug- coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm[J]. Int J Cardiovasc Imaging, 2019, 35: 579- 586.
[16] 李锦爽,王万虹,周 浩,等. 药物洗脱球囊治疗糖尿病伴复杂冠状动脉病变的临床效果[J]. 介入放射学杂志, 2019, 28:770- 772.
[17] Kleber FX, Schulz A, Waliszewski M, et al. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty[J]. Clin Res Cardiol, 2015, 104: 217- 225.

相似文献/References:

[1]刘 蓉,马士新,赵 钢,等.紫杉醇药物涂层球囊扩张冠状动脉支架内再狭窄病变增加远期管腔面积 [J].介入放射学杂志,2017,(04):367.
 LIU Rong,MA Shixing,ZHAO Gang,et al.Long- term lumen area enlarged in coronary in- stent restenosis after the treatment of paclitaxel drug - coated balloon dilatation[J].journal interventional radiology,2017,(12):367.
[2]项以力,张温凯,杨 镛.药物涂层球囊和无涂层球囊治疗股腘动脉缺血性疾病疗效及安全性meta分析 [J].介入放射学杂志,2017,(06):500.
 XIANG Yili,ZHANG Wenkai,YANG Yong.Drug- coated balloon versus uncoated balloon angioplasty for femoropopliteal artery ischemic disease: a meta- analysis of curative effect and safety[J].journal interventional radiology,2017,(12):500.
[3]刘晓哲,王 兵,刘俊超,等.药物涂层球囊在股腘动脉支架内再狭窄治疗中的应用 [J].介入放射学杂志,2018,27(05):410.
 LIU Xiaozhe,WANG Bing,LIU Junchao,et al.Application of drug- coated balloon in treating femoropopliteal in- stent restenosis[J].journal interventional radiology,2018,27(12):410.
[4]张成超,谷涌泉,齐立行,等.药物涂层球囊扩张成形术治疗颈动脉支架内再狭窄2例[J].介入放射学杂志,2019,28(02):159.
 ZHANG Chengchao,GU Yongquan,QI Lixing,et al.Drug- coated balloon dilatation for the treatment of carotid in- stent restenosis: initial results in 2 patients[J].journal interventional radiology,2019,28(12):159.

备注/Memo

备注/Memo:
(收稿日期:2019- 12- 28)
(本文编辑:边 佶)
更新日期/Last Update: 2020-12-16